secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2022-10-13T23:59:59+00:00
Accession:  0001193125-22-262172
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sotera Health director Stephanie Geveda resigns; Robert Knauss appointed as Class III director
--------------------------------------------------------------------------------

- Stephanie M. Geveda resigned from the Board on October 7, 2022, upon her departure from Warburg Pincus.
- Geveda confirmed no disagreement with the Company, management, or Board regarding operations or policies.
- Robert B. Knauss, a Warburg Pincus Managing Director, appointed as Class III director effective October 12, 2022.
- Appointment made under Stockholders Agreement granting Warburg Pincus director designation rights; Knauss deemed independent per Nasdaq rules.
- Knauss will receive standard non-employee director compensation (cash retainer + RSUs) and entered a customary indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000119312522262172/0001193125-22-262172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000119312522262172/d412955d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-262172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer